# PLCE1

## Overview
PLCE1, or phospholipase C epsilon 1, is a gene that encodes a member of the phospholipase C family of enzymes, which are integral to cellular signal transduction processes. The protein product, phospholipase C epsilon 1, is a multifunctional enzyme that plays a pivotal role in various cellular activities, including the regulation of the actin cytoskeleton, cell migration, and proliferation. It is characterized by its complex structure, which includes domains such as CDC25 homology, Ras-associating, and pleckstrin homology, facilitating interactions with small GTPases like Ras and RhoA (Song2001Regulation; Zhou2009Molecular). PLCE1 is activated by G proteins and small GTPases, leading to the production of second messengers that are crucial for intracellular signaling pathways (Kanemaru2023Activation). Clinically, PLCE1 is significant due to its association with various cancers and nephrotic syndromes, making it a potential biomarker for disease prognosis and a target for therapeutic interventions (Abdou2022Mutational; Wang2020Oncogene).

## Structure
The PLCE1 protein is a member of the phospholipase C family, characterized by a complex molecular structure that includes several functional domains. It contains a CDC25 homology domain, which is involved in guanine nucleotide exchange, and a Ras-associating (RA) domain, which facilitates interactions with small GTPases like Ras (Song2001Regulation). The protein also features a pleckstrin homology (PH) domain, EF-hand motifs, and C2 domains, which are common in phospholipase C proteins and contribute to its role in signal transduction (Zhou2009Molecular).

PLCE1 has a catalytic core composed of X and Y domains, essential for its enzymatic activity in hydrolyzing phosphatidylinositol 4,5-bisphosphate to generate second messengers (Zhou2009Molecular). The protein's structure is further distinguished by the presence of a unique Y-insert sequence, which is associated with Rho-dependent activation (Zhou2009Molecular).

Post-translational modifications, such as phosphorylation, may regulate PLCE1's activity, although specific details on these modifications are not provided in the context. The protein's spatial structure is influenced by single nucleotide polymorphisms (SNPs), which can alter its catalytic activity and efficiency, particularly in calcium-related pathways (Hu2021PLCE1).

## Function
PLCE1, or phospholipase C epsilon 1, is a multifunctional enzyme involved in various cellular processes in healthy human cells. It plays a critical role in the regulation of podocyte functions, which are essential for kidney filtration. PLCE1 interacts with small GTPases such as Rac1 and RhoA, influencing the actin cytoskeleton and thereby affecting podocyte migration, proliferation, and differentiation (Yu2020PLCE1). The enzyme acts as a RasGEF, transducing mitogenic signals to stimulate the Ras and mitogen-activated protein kinase (MAPK) signaling pathway, which is crucial for cell migration and proliferation (Yu2020PLCE1).

PLCE1 is activated by G proteins and small GTPases, leading to the production of diacylglycerol (DAG) and inositol trisphosphate (IP3), which increase intracellular calcium concentration and activate protein kinase C (Kanemaru2023Activation). This activity is important for maintaining the actin cytoskeleton and cellular processes vital for kidney function (Yu2020PLCE1). PLCE1's interaction with Ras proteins facilitates its translocation to the plasma membrane, enhancing its enzymatic activity and involvement in signal transduction pathways (Song2001Regulation). These molecular activities underscore PLCE1's role in maintaining cellular integrity and function in various tissues.

## Clinical Significance
The PLCE1 gene is clinically significant due to its association with various diseases, particularly cancers and nephrotic syndromes. In the context of cancer, PLCE1 is identified as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma (HCC), with high expression levels linked to poor prognosis. It is involved in cell cycle regulation, proliferation, migration, and invasion in HCC cell lines (Wang2020Oncogene). PLCE1 is also implicated in esophageal squamous cell carcinoma (ESCC) and gastric cancer, where germline genetic variants are associated with increased cancer risk, particularly in Chinese populations (Li2014PLCE1). The rs2274223 polymorphism in PLCE1 is linked to an increased risk of esophageal and gastric cancers, especially in Asian populations (Xue2015Association).

In nephrology, mutations in PLCE1 are associated with steroid-resistant nephrotic syndrome (SRNS) and congenital nephrotic syndrome. These mutations can lead to early-onset nephrotic syndrome and progressive renal failure (Abdou2022Mutational). The gene's mutations have been identified in families with SRNS, with some mutations being truncating or missense, suggesting a pathogenic role (Boyer2010Mutational). These findings highlight the gene's role in both oncological and renal pathologies.

## Interactions
PLCE1 (phospholipase C epsilon 1) is involved in various protein interactions that influence its function in cellular signaling pathways. It interacts with small GTPases such as Ras and Rap, which are crucial for its activation and regulation. Ras and Rap bind directly to the RA2 domain of PLCE1, facilitating its translocation from the cytosol to the membrane, a step important for its activation (Smrcka2012Role). PLCE1 also interacts with RhoA and Rac1 in podocytes, with these interactions occurring in the cell bodies and processes of these cells. The pleckstrin homology (PH) domain and the Ras-binding (RA) domains of PLCE1 are responsible for these interactions (Yu2020PLCE1).

PLCE1 forms complexes with other proteins, such as BRAF, although this interaction is likely indirect. BRAF and PLCE1 colocalize in glomerular podocytes, suggesting a functional relationship in kidney cells (Chaib2008Identification). PLCE1 also interacts with NCK2, a protein involved in actin cytoskeleton regulation, which is crucial for podocyte migration (Yu2020PLCE1). These interactions highlight the role of PLCE1 in regulating cellular processes such as migration, proliferation, and differentiation, particularly in podocytes.


## References


[1. (Yu2020PLCE1) Seyoung Yu, Won-Il Choi, Yo Jun Choi, Hye-Youn Kim, Friedhelm Hildebrandt, and Heon Yung Gee. Plce1 regulates the migration, proliferation, and differentiation of podocytes. Experimental &amp; Molecular Medicine, 52(4):594–603, April 2020. URL: http://dx.doi.org/10.1038/s12276-020-0410-4, doi:10.1038/s12276-020-0410-4. This article has 27 citations.](https://doi.org/10.1038/s12276-020-0410-4)

[2. (Boyer2010Mutational) O. Boyer, G. Benoit, O. Gribouval, F. Nevo, A. Pawtowski, I. Bilge, Z. Bircan, G. Deschenes, L. M. Guay-Woodford, M. Hall, M.-A. Macher, K. Soulami, C. J. Stefanidis, R. Weiss, C. Loirat, M.-C. Gubler, and C. Antignac. Mutational analysis of the plce1 gene in steroid resistant nephrotic syndrome. Journal of Medical Genetics, 47(7):445–452, June 2010. URL: http://dx.doi.org/10.1136/jmg.2009.076166, doi:10.1136/jmg.2009.076166. This article has 70 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.2009.076166)

[3. (Wang2020Oncogene) Xiang‐Kun Wang, Xi‐Wen Liao, Cheng‐Kun Yang, Zheng‐Qian Liu, Quan‐Fa Han, Xin Zhou, Lin‐Bo Zhang, Teng Deng, Yi‐Zhen Gong, Jian‐Lu Huang, Rui Huang, Chuang‐Ye Han, Ting‐Dong Yu, Hao Su, Xin‐Ping Ye, Tao Peng, and Guang‐Zhi Zhu. Oncogene plce1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines. Journal of Cellular Physiology, 235(10):7003–7017, February 2020. URL: http://dx.doi.org/10.1002/jcp.29596, doi:10.1002/jcp.29596. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.29596)

[4. (Abdou2022Mutational) Mohammed Abdou, Abeer Ramadan, Basma E. El-Agamy, Mohamed S. EL-Farsy, and Eman M. Saleh. Mutational analysis of phospholipase c epsilon 1 gene in egyptian children with steroid-resistant nephrotic syndrome. Egyptian Journal of Medical Human Genetics, November 2022. URL: http://dx.doi.org/10.1186/s43042-022-00353-2, doi:10.1186/s43042-022-00353-2. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s43042-022-00353-2)

[5. (Li2014PLCE1) Wen-Qing Li, Nan Hu, Victoria H. Burton, Howard H. Yang, Hua Su, Catherine M. Conway, Lemin Wang, Chaoyu Wang, Ti Ding, Yi Xu, Carol Giffen, Christian C. Abnet, Alisa M. Goldstein, Stephen M. Hewitt, and Philip R. Taylor. Plce1 mrna and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma. Cancer Epidemiology, Biomarkers &amp; Prevention, 23(8):1579–1588, July 2014. URL: http://dx.doi.org/10.1158/1055-9965.EPI-13-1329, doi:10.1158/1055-9965.epi-13-1329. This article has 42 citations.](https://doi.org/10.1158/1055-9965.EPI-13-1329)

[6. (Xue2015Association) Wenji Xue, Meiling Zhu, Yiwei Wang, Jing He, and Leizhen Zheng. Association between plce1 rs2274223 a &gt; g polymorphism and cancer risk: proof from a meta-analysis. Scientific Reports, January 2015. URL: http://dx.doi.org/10.1038/srep07986, doi:10.1038/srep07986. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep07986)

[7. (Hu2021PLCE1) Xi’e Hu, Jintong Jia, Zhenyu Yang, Songhao Chen, Jingyi Xue, Sensen Duan, Ping Yang, Shujia Peng, Lin Yang, Lijuan Yuan, and Guoqiang Bao. Plce1 polymorphisms are associated with gastric cancer risk: the changes in protein spatial structure may play a potential role. Frontiers in Genetics, August 2021. URL: http://dx.doi.org/10.3389/fgene.2021.714915, doi:10.3389/fgene.2021.714915. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.714915)

[8. (Kanemaru2023Activation) Kaori Kanemaru and Yoshikazu Nakamura. Activation mechanisms and diverse functions of mammalian phospholipase c. Biomolecules, 13(6):915, May 2023. URL: http://dx.doi.org/10.3390/biom13060915, doi:10.3390/biom13060915. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13060915)

[9. (Zhou2009Molecular) Weibin Zhou and Friedhelm Hildebrandt. Molecular cloning and expression of phospholipase c epsilon 1 in zebrafish. Gene Expression Patterns, 9(5):282–288, June 2009. URL: http://dx.doi.org/10.1016/j.gep.2009.03.003, doi:10.1016/j.gep.2009.03.003. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gep.2009.03.003)

[10. (Smrcka2012Role) Alan V. Smrcka, Joan Heller Brown, and George G. Holz. Role of phospholipase cε in physiological phosphoinositide signaling networks. Cellular Signalling, 24(6):1333–1343, June 2012. URL: http://dx.doi.org/10.1016/j.cellsig.2012.01.009, doi:10.1016/j.cellsig.2012.01.009. This article has 127 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2012.01.009)

[11. (Song2001Regulation) Chunhua Song, Chang-Deng Hu, Misa Masago, Ken-ichi Kariya, Yuriko Yamawaki-Kataoka, Mitsushige Shibatohge, Dongmei Wu, Takaya Satoh, and Tohru Kataoka. Regulation of a novel human phospholipase c, plcε, through membrane targeting by ras. Journal of Biological Chemistry, 276(4):2752–2757, January 2001. URL: http://dx.doi.org/10.1074/jbc.m008324200, doi:10.1074/jbc.m008324200. This article has 267 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m008324200)

[12. (Chaib2008Identification) Hassan Chaib, Bethan E. Hoskins, Shazia Ashraf, Meera Goyal, Roger C. Wiggins, and Friedhelm Hildebrandt. Identification of braf as a new interactor of plcε1, the protein mutated in nephrotic syndrome type 3. American Journal of Physiology-Renal Physiology, 294(1):F93–F99, January 2008. URL: http://dx.doi.org/10.1152/ajprenal.00345.2007, doi:10.1152/ajprenal.00345.2007. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.00345.2007)